‘Loving, caring' Rhuddlan mother will be ‘hugely missed'
Ann Winifred Sellwood, of Highlands Road in Rhuddlan, died aged 72 at the Bodelwyddan hospital on December 14, 2023.
At the resumption of the inquest into her death, held in Ruthin today (June 20), John Gittins, senior coroner for North Wales East and Central, gave a medical cause of death of pneumonia as a result of a fall with rib fractures and chronic pulmonary disease and contributing pulmonary heart disease.
Mrs Sellwood was born in Accrington on December 8, 1951, and was a retired nurse who had also run a pub with her husband Paul.
Her son Paul told the inquest his mother had 'loved people', and described her as a 'great, loving, caring' person who 'looked after other people before herself'.
In the five years before her death, her health had declined – she had arthritis in her back which caused mobility issues and 'made her introverted and reserved over time'.
She also had a history of chronic obstructive pulmonary disease (COPD), and was on medication including an inhaler.
The inquest was told she had suffered some falls in the months prior to her death, and had been admitted to Ysbyty Glan Clwyd in October (7-11), November (1-10) and again between November 25 and December 4.
This was because of low sodium levels, and these levels had dropped during hospital visits.
Upon her second admission to Glan Clwyd, her sodium levels were again low, with a cut on her thigh evidence of a fall four weeks prior.
Dr Sanghamitra Chakrabarti, a consultant in acute geriatrics who treated Mrs Sellwood, said they started her on steroid replacement medication, which gradually saw her sodium levels improve.
She was discharged on November 10 having 'never complained of chest pain or cardiac problems during this admission', and was given medication to take twice a day.
However, between this and her third admission, her husband said she had started to deteriorate after around a week out of hospital.
Her third admission to hospital came after another fall, and her sodium levels decreased for several days before a diagnosis of syndrome of inappropriate antidiuretic hormone secretion (SIADH), which causes sodium levels to be lower.
Dr Aye Nyunt, a consultant in general surgery, said Mrs Sellwood's sodium levels increased on December 3 and 4, and she was discharged again and prescribed Tolvaptan, which treats low sodium in the blood.
READ MORE:
Woman who died in crash on A548 coast road is named
Abergele man died after falling from mountain range in Eryri
Despite there being no plan to discharge her on December 1 (a Friday), Mrs Sellwood was moved to a different ward by December 4 in anticipation of her discharge.
Dr Nyunt described Mrs Sellwood as 'mobilising independently, eating and drinking' on December 4, and was not aware of the family's concerns regarding the decision to discharge her at the time.
She said Mrs Sellwood's sodium levels were 'safe enough' to be discharged, with her GP to monitor these levels weekly.
Her husband Paul said the family 'disagreed on a number of occasions when told she was good to go home' and were 'given medication and not told how to use it', which he told the inquest was 'very upsetting'.
Her behaviour became 'more erratic' after the third discharge from hospital, and she fell at home in the intervening period – her son Paul described her eating habits as 'really abnormal' and 'like she was starving'.
He said she was not 'sound of mind' at that time, and that he felt they 'should have taken her back' to Glan Clwyd again.
On December 8, she had blood tests done at her GP surgery, but the results, which show low sodium levels, did not come back until the following Monday (December 11).
Later that day, Mrs Sellwood fell against a worktop at home and was 'screaming in absolute agony', and in the early hours of December 9 was re-admitted to Ysbyty Glan Clwyd.
A CT scan was done on December 10, which showed rib fractures to her right side, but despite further monitoring and investigation, she died on December 14.
Dr Huyam Abdalsalam, a consultant pathologist at Ysbyty Glan Clwyd, said Mrs Sellwood showed signs of cardiac disease and pneumonia, with the latter considered the terminal event.
Her medical cause of death was pneumonia with contributing rib fractures and underlying smoking and heart disease.
Mr Gittins gave a narrative conclusion, and confirmed a medical cause of death of pneumonia as a result of a fall with rib fractures and chronic pulmonary disease and contributing pulmonary heart disease.
He said: 'On December 8 dec the deceased had a blood test at her GP surgery.
'When analysed, neither she nor her family were made aware of the results.
'That evening, she collapsed in her bedroom and sustained rib injuries which resulted in her death on December 14.
Mr Gittins said that there were 'concerns that need addressing', with the health board set to investigate and conduct enquiries into how GP test results were conveyed between departments.
Addressing Mrs Sellwood's family, he expressed his condolences on the 'loss of a lady who is hugely missed'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Rhyl Journal
20-06-2025
- Rhyl Journal
‘Loving, caring' Rhuddlan mother will be ‘hugely missed'
Ann Winifred Sellwood, of Highlands Road in Rhuddlan, died aged 72 at the Bodelwyddan hospital on December 14, 2023. At the resumption of the inquest into her death, held in Ruthin today (June 20), John Gittins, senior coroner for North Wales East and Central, gave a medical cause of death of pneumonia as a result of a fall with rib fractures and chronic pulmonary disease and contributing pulmonary heart disease. Mrs Sellwood was born in Accrington on December 8, 1951, and was a retired nurse who had also run a pub with her husband Paul. Her son Paul told the inquest his mother had 'loved people', and described her as a 'great, loving, caring' person who 'looked after other people before herself'. In the five years before her death, her health had declined – she had arthritis in her back which caused mobility issues and 'made her introverted and reserved over time'. She also had a history of chronic obstructive pulmonary disease (COPD), and was on medication including an inhaler. The inquest was told she had suffered some falls in the months prior to her death, and had been admitted to Ysbyty Glan Clwyd in October (7-11), November (1-10) and again between November 25 and December 4. This was because of low sodium levels, and these levels had dropped during hospital visits. Upon her second admission to Glan Clwyd, her sodium levels were again low, with a cut on her thigh evidence of a fall four weeks prior. Dr Sanghamitra Chakrabarti, a consultant in acute geriatrics who treated Mrs Sellwood, said they started her on steroid replacement medication, which gradually saw her sodium levels improve. She was discharged on November 10 having 'never complained of chest pain or cardiac problems during this admission', and was given medication to take twice a day. However, between this and her third admission, her husband said she had started to deteriorate after around a week out of hospital. Her third admission to hospital came after another fall, and her sodium levels decreased for several days before a diagnosis of syndrome of inappropriate antidiuretic hormone secretion (SIADH), which causes sodium levels to be lower. Dr Aye Nyunt, a consultant in general surgery, said Mrs Sellwood's sodium levels increased on December 3 and 4, and she was discharged again and prescribed Tolvaptan, which treats low sodium in the blood. READ MORE: Woman who died in crash on A548 coast road is named Abergele man died after falling from mountain range in Eryri Despite there being no plan to discharge her on December 1 (a Friday), Mrs Sellwood was moved to a different ward by December 4 in anticipation of her discharge. Dr Nyunt described Mrs Sellwood as 'mobilising independently, eating and drinking' on December 4, and was not aware of the family's concerns regarding the decision to discharge her at the time. She said Mrs Sellwood's sodium levels were 'safe enough' to be discharged, with her GP to monitor these levels weekly. Her husband Paul said the family 'disagreed on a number of occasions when told she was good to go home' and were 'given medication and not told how to use it', which he told the inquest was 'very upsetting'. Her behaviour became 'more erratic' after the third discharge from hospital, and she fell at home in the intervening period – her son Paul described her eating habits as 'really abnormal' and 'like she was starving'. He said she was not 'sound of mind' at that time, and that he felt they 'should have taken her back' to Glan Clwyd again. On December 8, she had blood tests done at her GP surgery, but the results, which show low sodium levels, did not come back until the following Monday (December 11). Later that day, Mrs Sellwood fell against a worktop at home and was 'screaming in absolute agony', and in the early hours of December 9 was re-admitted to Ysbyty Glan Clwyd. A CT scan was done on December 10, which showed rib fractures to her right side, but despite further monitoring and investigation, she died on December 14. Dr Huyam Abdalsalam, a consultant pathologist at Ysbyty Glan Clwyd, said Mrs Sellwood showed signs of cardiac disease and pneumonia, with the latter considered the terminal event. Her medical cause of death was pneumonia with contributing rib fractures and underlying smoking and heart disease. Mr Gittins gave a narrative conclusion, and confirmed a medical cause of death of pneumonia as a result of a fall with rib fractures and chronic pulmonary disease and contributing pulmonary heart disease. He said: 'On December 8 dec the deceased had a blood test at her GP surgery. 'When analysed, neither she nor her family were made aware of the results. 'That evening, she collapsed in her bedroom and sustained rib injuries which resulted in her death on December 14. Mr Gittins said that there were 'concerns that need addressing', with the health board set to investigate and conduct enquiries into how GP test results were conveyed between departments. Addressing Mrs Sellwood's family, he expressed his condolences on the 'loss of a lady who is hugely missed'.
Daily Mirror
19-06-2025
- Daily Mirror
'Without PIP you hit rock bottom - benefit cuts are kicking us when we're down'
Recipients of disability benefits and PIP have hit out at the UK Government as a 'catastrophic' benefits cut bill was revealed with many left 'terrified' that their financial support will be taken away People who rely on disability benefits including PIP have hit out at the government after new legislation was published which shows plans aiming to slash £5 billion from the welfare bill in the next five years. As the government published its controversial benefits bill, overhauling the system for recipients of Universal Credit and Personal Independence Payments, the Mirror spoke to everyday people who have been left terrified by the proposals. Paul Harris, 45, from Barnard Castle, Co Durham, started claiming benefits when a mental breakdown left him unable to work eight years ago. Now, he's scared his financial support will be taken away, and fears becoming a 'burden' on his wife. After being diagnosed with anxiety and depression, Paul defaulted on bank loans and credit cards, and eventually relocated from Bedfordshire to the north in an effort to reduce his costs. He tried medication but suffered night terrors as a side effect and has exhausted the help available to him on the NHS. He uses his PIP and ESA payments, which equate to around £800 a month, to pay for essentials such as food and bills as well as using supplements to manage his anxiety and depression. Paul told the Mirror: "On the very bad days I'm back in bed with the curtains closed. "Last time I tried opening my CV I had a panic attack, I wouldn't even know what job to try and apply for, I struggle even getting on job websites, the anxiety builds even thinking about it." Paul, who worked in hotel reservations before becoming a property negotiator, says many of his anxious triggers are work related following his breakdown. It left him so physically debilitated he would lock himself in the work bathroom while having panic attacks and eventually was so unwell he couldn't even get ready for work. He added: "I already had a two year battle to have PIP reinstated a couple of years ago and at the time I used to call myself 'zero' because I wasn't bringing any money in. "I didn't feel like I was contributing anything and everything was on my wife. That had a massive negative impact. Having the money doesn't cure it but it gives you a little something to work from. Without PIP you hit rock bottom." Now the government's benefits bill means Paul and his wife Kim could face a £290 cut to their monthly income if his PIP payments are removed again. He said: "It's terrifying. It's that feeling of being completely misunderstood. "I have a lot of problems anyway feeling like a burden to my wife because she's the sole earner and it's had a massive impact on her mental health as well. If she can't work because she's self-employed, what do we do then? "I've exhausted all the NHS can do now the government wants to take my financial support away. How many more people do they want to kick while they're down?"
Scottish Sun
13-06-2025
- Scottish Sun
NHS first in the world to roll out ‘trogan horse' cancer treatment that ‘drastically slows disease'
A "TROJAN HORSE" therapy that sneaks toxic drugs inside and kills cancer cells is being rolled out on the NHS in England in a world first. It can stop the blood cancer myeloma from progressing for nearly three times longer than current therapies. 2 Paul Silvester having his treatment at Royal Hallamshire Hospital in Sheffield. Credit: PA The treatment, known as belantamab mafodotin or Blenrep, is an advanced form of chemotherapy. It delivers a powerful dose of cancer-killing medication directly into cancer cells, while limiting damage to healthy cells, reducing the risk of harsh side effects. Around 1,500 people a year with multiple myeloma, a rare, incurable cancer of the bone marrow, are expected to benefit from the treatment. Paul Silvester, 60, from Sheffield, is one of the first patients to receive the new drug through an early access programme. Diagnosed with myeloma in July 2023, Paul was initially given a different treatment, but when it failed to stop his cancer from progressing, doctors turned to belantamab mafodotin. 'I feel like this treatment has brought the party balloons back in the house,' he said. 'It has been amazing - within the first two or three weeks, after the first dose, I was in remission. "It gives me quite a lot of confidence in the drugs and it makes me more optimistic about the future. "I've been feeling well and I'm still quite active - that's what's important in terms of your quality of life. "One of my daughters is graduating from university in October and it's a goal for me to be there." British rock legend reveals he's fighting aggressive blood cancer and is undergoing treatment The therapy, developed by GlaxoSmithKline, is administered via infusion every three weeks alongside two other drugs: bortezomib and dexamethasone. Clinical trials showed it could delay the progression of myeloma for around three years, compared to just over a year for patients receiving commonly used drug daratumumab with the same combination. Following new guidance from NICE (the National Institute for Health and Care Excellence), the drug has now been approved for widespread NHS use in England. It's the first health system in the world to offer it routinely. Patients who have relapsed or not responded to earlier treatments will now be eligible for the therapy. The treatment has been nicknamed a 'Trojan horse' because of how it works. 2 Much like the famous story from ancient Greek mythology where soldiers hid inside a giant wooden horse to secretly enter the city of Troy, this drug hides a toxic payload inside an antibody that tricks cancer cells into letting it in. Once inside, it releases a powerful, cell-killing molecule that destroys the cancer from within, while sparing surrounding healthy cells. 'New hope' Professor Peter Johnson, NHS England's national clinical director for cancer, said: 'Myeloma is an aggressive type of blood cancer, but we have seen a steady improvement in the outlook for patients over recent years as we have introduced new targeted therapies. 'I am delighted that patients in England will be the first to benefit from this new treatment, which has the potential to keep cancer at bay for years longer, giving people the chance of more precious time with friends and family. 'This treatment could be life-changing for many patients and their families, and that's why it is so important that the NHS continues to secure quick access to the latest, innovative treatments like this, at affordable prices to the taxpayer.' Helen Knight, director of medicines evaluation at NICE, added: 'We're delighted that people in the UK will become among the first in the world to access belantamab mafodotin for this indication. "This recommendation demonstrates our commitment to getting the best care to patients fast, while ensuring value for the taxpayer." Myeloma UK, a charity supporting those with blood cancer, has also welcomed the news. Shelagh McKinlay, its director of research and advocacy, said: 'It's fantastic to see the UK at the forefront of myeloma treatment. 'We have been working very hard for the last year to get this treatment approved and we know it will transform the lives of thousands of people with myeloma.' Health Minister Karin Smyth added: 'This groundbreaking therapy puts the NHS at the forefront of cancer innovation. "By harnessing cutting-edge 'trojan horse' technology, we're offering new hope to blood cancer patients across the country."
